Restifo, Nicholas P.
National Cancer Institute (NCI),
United States
2025 Rank: 3011
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 111 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 3011 | 3078 |
| Total Cites | 71042 | 77478 |
| H-index | 130 | 137 |
| Hm-index | 39 | 41 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 556 | 593 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 4029 | 4270 |
| Number of Single+First+Last Authored Papers | 174 | 174 |
| Total Cites to Single+First+Last Authored Papers | 34411 | 37319 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 41306 | 42787 |
| Ratio of Total Citations to Distinct Citing Papers | 1.72 | 1.81 |
| Self-Citation Percentage |
8.31%
|
|
Restifo, Nicholas P.
National Institutes of Health (NIH),
United States
2024 Rank: 2776
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 108 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 2776 | 2887 |
| Total Cites | 67205 | 73559 |
| H-index | 130 | 135 |
| Hm-index | 39 | 41 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 551 | 588 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 3877 | 4123 |
| Number of Single+First+Last Authored Papers | 175 | 175 |
| Total Cites to Single+First+Last Authored Papers | 32443 | 35318 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 38711 | 40169 |
| Ratio of Total Citations to Distinct Citing Papers | 1.74 | 1.83 |
| Self-Citation Percentage |
8.64%
|
|
Restifo, Nicholas P.
National Cancer Institute (NCI),
United States
2023 Rank: 2542
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 102 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 2542 | 2626 |
| Total Cites | 64794 | 71333 |
| H-index | 128 | 134 |
| Hm-index | 39 | 42 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 545 | 582 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 3694 | 3948 |
| Number of Single+First+Last Authored Papers | 188 | 188 |
| Total Cites to Single+First+Last Authored Papers | 30853 | 33790 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 37017 | 38514 |
| Ratio of Total Citations to Distinct Citing Papers | 1.75 | 1.85 |
| Self-Citation Percentage |
9.17%
|
|
Restifo, Nicholas P.
National Cancer Institute (NCI),
United States
2022 Rank: 2471
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 101 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 2471 | 2533 |
| Total Cites | 59071 | 65401 |
| H-index | 123 | 129 |
| Hm-index | 39 | 41 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 535 | 572 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 3464 | 3715 |
| Number of Single+First+Last Authored Papers | 184 | 184 |
| Total Cites to Single+First+Last Authored Papers | 28163 | 31028 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 33474 | 34901 |
| Ratio of Total Citations to Distinct Citing Papers | 1.76 | 1.87 |
| Self-Citation Percentage |
9.68%
|
|
Restifo, Nicholas P.
National Cancer Institute (NCI),
United States
2021 Rank: 2417
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 96 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 2417 | 2493 |
| Total Cites | 56182 | 62343 |
| H-index | 121 | 125 |
| Hm-index | 38 | 41 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 529 | 566 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 3346 | 3593 |
| Number of Single+First+Last Authored Papers | 183 | 183 |
| Total Cites to Single+First+Last Authored Papers | 26737 | 29524 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 31810 | 33195 |
| Ratio of Total Citations to Distinct Citing Papers | 1.77 | 1.88 |
| Self-Citation Percentage |
9.88%
|
|
Restifo, Nicholas P.
National Cancer Institute,
United States
2020 Rank: 2547
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 96 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 2547 | 2558 |
| Total Cites | 49604 | 55573 |
| H-index | 113 | 120 |
| Hm-index | 36 | 38 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 522 | 559 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 3036 | 3282 |
| Number of Single+First+Last Authored Papers | 181 | 181 |
| Total Cites to Single+First+Last Authored Papers | 23525 | 26231 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 27868 | 29200 |
| Ratio of Total Citations to Distinct Citing Papers | 1.78 | 1.90 |
| Self-Citation Percentage |
10.74%
|
|